Emphysema Market Key Trend: Growing Focus On Personalized Medicine

The Business Research Company's Emphysema Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034

LONDON, GREATER LONDON, UNITED KINGDOM, May 13, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Drivers, Trends, Regional Insights - Market Sizing & Forecasts Through 2034

How Big Is the Emphysema Market and How Fast Is It Growing?
The emphysema market, currently valued at $4.74 billion in 2024, is set to see steady growth in the coming years. By 2025, the market is expected to reach $4.99 billion, reflecting a compound annual growth rate (CAGR) of 5.2%. As we move into the forecast period, the market is anticipated to grow to $6.05 billion by 2029, maintaining a steady CAGR of 4.9%. This growth can be attributed to factors like the increasing prevalence of respiratory diseases, a rising aging population, smoking habits, and environmental pollution.

Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21956&type=smp

What Are the Key Trends Shaping the Emphysema Market?
Several significant trends are influencing the emphysema market, including advancements in inhalation therapy and a growing focus on personalized medicine. Companies are innovating with new treatments, such as inhaled dual inhibitors, to improve lung function and reduce inflammation. The shift towards telemedicine and the growing demand for minimally invasive procedures also play key roles in the evolution of this market. With the development of new inhalation devices and treatments, such as Verona Pharma’s Ohtuvayre, patients now have access to more effective therapeutic options, marking a milestone in chronic obstructive pulmonary disease (COPD) treatment.

Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/emphysema-global-market-report

What Is Driving the Market’s Growth?
The emphysema market is being significantly driven by the rising prevalence of respiratory infections, which accelerate disease progression. Factors like pollution, climate change, and antimicrobial resistance exacerbate respiratory conditions, contributing to increased emphysema cases. For example, the rise in tuberculosis cases in the United States, as reported by the CDC in 2024, is fueling this trend. As respiratory infections worsen lung function, the need for advanced treatments and diagnostics is more critical than ever.

Who Are the Leading Players in the Emphysema Market?
The key players in the emphysema market include some of the largest names in the pharmaceutical and medical device industries. These companies include:
• Pfizer Inc.
• Merck & Co. Inc.
• Sanofi S.A.
• AstraZeneca PLC
• Novartis International AG
• GlaxoSmithKline PLC
• Takeda Pharmaceutical Company Limited
• Koninklijke Philips N.V.
• Teva Pharmaceutical Industries Ltd.
• Boehringer Ingelheim
• Mylan N.V.
• Olympus Corporation
• ResMed Inc.
• Chiesi Farmaceutici S.p.A.
• University of Chicago Medicine (UChicago Medicine)
These companies are driving innovation through partnerships, acquisitions, and new product launches to strengthen their market positions and expand their treatment options for emphysema.

What Are the Segments in the Emphysema Market?
The emphysema market is segmented into the following key categories:
• By Type:
o Centrilobular
o Panlobular
• By Treatment:
o Medication
o Therapy
o Surgery
o Other Treatments
• By Diagnosis:
o Imaging Test
o Lung Function Test
o Other Diagnosis
• By Complications:
o Chest Infections
o Collapsed Lung
o Heart Problems
o Lung Hole
o Other Complications
• By End-user:
o Hospitals and Clinics
o Surgical Centers
o Other End-users

Which Regions Are Leading the Market Expansion?
The North American region currently holds the largest share of the emphysema market, driven by advanced healthcare infrastructure, high rates of smoking, and the prevalence of respiratory diseases. However, the Asia-Pacific region is expected to see the fastest growth in the coming years due to increasing healthcare spending, rising pollution levels, and a growing aging population in countries like China and India.

Request Customised Information On This Market Here:
https://www.thebusinessresearchcompany.com/customise?id=21956&type=smp

Browse Through More Similar Reports By The Business Research Company:

Emphysema Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/emphysema-treatment-global-market-report

Black Lung Disease Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/black-lung-disease-global-market-report

Lung Cancer Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report

About The Business Research Company
Learn More About The Business Research Company. With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch:
The Business Research Company: https://www.thebusinessresearchcompany.com
Americas: +1 315-623-0293
Asia: +44 207-193-0708
Europe: +44 207-193-0708
Email us: info@tbrc.info

connected:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X